X0609 4 2026-09-09 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001658369 Shenouda Maged false C/O RELMADA THERAPEUTICS, INC. 2222 PONCE DE LEON BLVD, 3RD FLOOR CORAL GABLES FL 33134 0 1 0 0 Chief Financial Officer 0 Common Stock 2026-09-09 4 P 0 120200 4.20 A 920200 D Common Stock 2026-09-10 4 P 0 79800 4.25 A 1000000 D The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $4.16 to $4.20 per share, inclusive. /s/ Maged Shenouda 2026-09-11